Tidal Investments’s Moderna MRNA Stock Holding History

Tidal Investments’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$270M	Sell	3,850,000 -1,132,000	-23%	-$58.6M	0.47%	31
2026 Q1	$253M	Buy	4,982,000 +1,070,000	+27%	+$49.9M	0.53%	27
2025 Q4	$115M	Sell	3,912,000 -4,058,000	-51%	-$110M	0.27%	68
2025 Q3	$206M	Buy	7,970,000 +7,901,420	+11,521%	+$220M	0.41%	37
2025 Q2	$10.3M	Buy	68,580 +17,100	+33%	+$450K	0.06%	312
2025 Q1	$3.08M	Buy	51,480 +21,360	+71%	+$758K	0.03%	521
2024 Q4	$1.33M	Buy	30,120 +23,360	+346%	+$1.12M	0.01%	873
2024 Q3	$419K	Buy	6,760 +4,400	+186%	+$404K	﹤0.01%	1459
2024 Q2	$60.2K	Buy	2,360 +230	+11%	+$29.1K	﹤0.01%	1762
2024 Q1	$1.49M	Buy	2,130 +1,835	+622%	+$185K	0.02%	683
2023 Q4	$226K	Buy	+295	New	+$24.8K	0.01%	1295

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Tidal Investments's MRNA Position: Q2 2026 in Review

Tidal Investments reduced its Moderna (MRNA) stake by 14% in Q2 2026, selling an estimated $706K and leaving 83,378 shares worth $5.84M. The position accounts for 0.01% of the portfolio, ranked #882.

Tidal Investments first reported a position in MRNA in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.68M in Q4 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Tidal Investments held 83,378 shares of Moderna worth $5.84M as of Q2 2026.
Tidal Investments sold 13,653 Moderna shares in Q2 2026, an estimated $706K.
Moderna made up 0.01% of Tidal Investments's portfolio in Q2 2026, its #882 holding.
Tidal Investments first reported a position in Moderna in Q4 2020 and has held it in 23 quarters since.
Tidal Investments's Moderna position peaked at $7.68M in Q4 2024.
783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.